Piper Sandler Maintains Overweight on Perspective Therapeutics, Lowers Price Target to $8

Benzinga · 2d ago
Piper Sandler analyst Biren Amin maintains Perspective Therapeutics (AMEX:CATX) with a Overweight and lowers the price target from $14 to $8.